The public view is the crawlable proof. The same sourced dataset is available through REST and MCP for agents, research scripts, and back-office tools.
| Date | Insider | Role | Action | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Jun 1, 2026 | Sarchi Christopher | Chief Commercial Officer | Sell(S) | 12K | $9.24 | $111K |
| May 18, 2026 | Hill Emily Luisa | Chief Financial Officer | Sell(S) | 8K | $5.08 | $40K |
| May 18, 2026 | Astley-Sparke Philip | Director | Sell(S) | 18K | $5.08 | $90K |
| May 18, 2026 | Patel Sushil | Chief Executive Officer, Director | Sell(S) | 37K | $5.08 | $190K |
| May 18, 2026 | Sarchi Christopher | Chief Commercial Officer | Sell(S) | 9K | $5.08 | $44K |
| May 18, 2026 | Schwendenman Andrew | Chief Accounting Officer | Sell(S) | 8K | $5.08 | $40K |
| May 18, 2026 | Xynos Konstantinos | Chief Medical Officer | Sell(S) | 14K | $5.08 | $71K |
| Apr 2, 2026 | Sarchi Christopher | Chief Commercial Officer | Sell(S) | 7K | $8.01 | $52K |
| Apr 1, 2026 | Astley-Sparke Philip | Director | Grant(A) | 50K | — | $0 |
| Apr 1, 2026 | Astley-Sparke Philip | Director | Grant(A) | 75K | — | $0 |
| Apr 1, 2026 | Dhingra Kapil | Director | Grant(A) | 45K | — | $0 |
| Apr 1, 2026 | Balachandran Madhavan | Director | Grant(A) | 45K | — | $0 |
| Apr 1, 2026 | Baker Bros. Advisors LP | Director, 10% Owner | Grant(A) | 45K | — | $0 |
| Apr 1, 2026 | Baker Bros. Advisors LP | Director, 10% Owner | Grant(A) | 45K | — | $0 |
| Apr 1, 2026 | Weinand Dieter | Director | Grant(A) | 45K | — | $0 |
| Apr 1, 2026 | Schwendenman Andrew | Chief Accounting Officer | Grant(A) | 37K | — | $0 |
| Apr 1, 2026 | Schwendenman Andrew | Chief Accounting Officer | Grant(A) | 55K | — | $0 |
| Apr 1, 2026 | Sarchi Christopher | Chief Commercial Officer | Grant(A) | 50K | — | $0 |
| Apr 1, 2026 | Sarchi Christopher | Chief Commercial Officer | Grant(A) | 75K | — | $0 |
| Apr 1, 2026 | Hill Emily Luisa | Chief Financial Officer | Grant(A) | 50K | — | $0 |
| Apr 1, 2026 | Hill Emily Luisa | Chief Financial Officer | Grant(A) | 75K | — | $0 |
| Apr 1, 2026 | Peeples-Dyer Veleka | Director | Grant(A) | 45K | — | $0 |
| Apr 1, 2026 | Oliger Christy J. | Director | Grant(A) | 45K | — | $0 |
| Apr 1, 2026 | Patel Sushil | Chief Executive Officer, Director | Grant(A) | 251K | — | $0 |
| Apr 1, 2026 | Patel Sushil | Chief Executive Officer, Director | Grant(A) | 377K | — | $0 |
| Apr 1, 2026 | Pucci Paolo | Director | Grant(A) | 45K | — | $0 |
| Apr 1, 2026 | Slattery Joseph P | Director | Grant(A) | 45K | — | $0 |
| Apr 1, 2026 | Xynos Konstantinos | Chief Medical Officer | Grant(A) | 50K | — | $0 |
| Apr 1, 2026 | Xynos Konstantinos | Chief Medical Officer | Grant(A) | 75K | — | $0 |
| Feb 18, 2026 | Astley-Sparke Philip | Director | Gift(G) | 25K | — | $0 |
| Dec 19, 2025 | Schwendenman Andrew | Chief Accounting Officer | Grant(A) | 10K | — | $0 |
| Dec 19, 2025 | Sarchi Christopher | Chief Commercial Officer | Grant(A) | 35K | — | $0 |
| Dec 19, 2025 | Hill Emily Luisa | Chief Financial Officer | Grant(A) | 60K | — | $0 |
| Dec 19, 2025 | Xynos Konstantinos | Chief Medical Officer | Grant(A) | 60K | — | $0 |
| Dec 19, 2025 | Patel Sushil | Chief Executive Officer, Director | Grant(A) | 200K | — | $0 |
| Dec 9, 2025 | Dhingra Kapil | Director | Sell(S) | 3K | $10.40 | $33K |
| Dec 9, 2025 | Dhingra Kapil | Director | Option exercise(M) | 3K | $1.75 | $6K |
| Dec 9, 2025 | Dhingra Kapil | Director | Option exercise(M) | 3K | — | $0 |
| Dec 2, 2025 | Patel Sushil | Chief Executive Officer, Director | Sell(S) | 10K | $11.13 | $111K |
| Nov 17, 2025 | Xynos Konstantinos | Chief Medical Officer | Sell(S) | 7K | $9.10 | $66K |
| Nov 17, 2025 | Sarchi Christopher | Chief Commercial Officer | Sell(S) | 5K | $9.10 | $47K |
| Aug 15, 2025 | Hill Emily Luisa | Chief Financial Officer | Sell(S) | 9K | $5.37 | $49K |
| May 20, 2025 | Sarchi Christopher | Chief Commercial Officer | Sell(S) | 4K | $8.05 | $30K |
| May 20, 2025 | Hill Emily Luisa | Chief Financial Officer | Sell(S) | 3K | $8.05 | $20K |
| May 20, 2025 | Patel Sushil | Chief Executive Officer, Director | Sell(S) | 25K | $8.06 | $202K |
| May 20, 2025 | Schwendenman Andrew | Chief Accounting Officer | Sell(S) | 3K | $8.05 | $26K |
| May 20, 2025 | Xynos Konstantinos | Chief Medical Officer | Sell(S) | 8K | $8.06 | $64K |
| May 20, 2025 | Astley-Sparke Philip | Director | Sell(S) | 32K | $8.06 | $260K |
| Apr 1, 2025 | Schwendenman Andrew | Chief Accounting Officer | Grant(A) | 33K | — | $0 |
| Apr 1, 2025 | Schwendenman Andrew | Chief Accounting Officer | Grant(A) | 50K | — | $0 |
| Apr 1, 2025 | Oliger Christy J. | Director | Grant(A) | 32K | — | $0 |
| Apr 1, 2025 | Sarchi Christopher | Chief Commercial Officer | Grant(A) | 45K | — | $0 |
| Apr 1, 2025 | Sarchi Christopher | Chief Commercial Officer | Grant(A) | 68K | — | $0 |
| Apr 1, 2025 | Weinand Dieter | Director | Grant(A) | 32K | — | $0 |
| Apr 1, 2025 | Hill Emily Luisa | Chief Financial Officer | Grant(A) | 45K | — | $0 |
| Apr 1, 2025 | Hill Emily Luisa | Chief Financial Officer | Grant(A) | 68K | — | $0 |
| Apr 1, 2025 | Slattery Joseph P | Director | Grant(A) | 32K | — | $0 |
| Apr 1, 2025 | Dhingra Kapil | Director | Grant(A) | 32K | — | $0 |
| Apr 1, 2025 | Xynos Konstantinos | Chief Medical Officer | Grant(A) | 45K | — | $0 |
| Apr 1, 2025 | Xynos Konstantinos | Chief Medical Officer | Grant(A) | 68K | — | $0 |
| Apr 1, 2025 | Balachandran Madhavan | Director | Grant(A) | 32K | — | $0 |
| Apr 1, 2025 | Pucci Paolo | Director | Grant(A) | 32K | — | $0 |
| Apr 1, 2025 | Patel Sushil | Chief Executive Officer, Director | Grant(A) | 167K | — | $0 |
| Apr 1, 2025 | Patel Sushil | Chief Executive Officer, Director | Grant(A) | 250K | — | $0 |
| Apr 1, 2025 | Peeples-Dyer Veleka | Director | Grant(A) | 32K | — | $0 |
| Mar 5, 2025 | Baker Bros. Advisors (GP) LLC | Director, 10% Owner | Grant(A) | 64K | — | $0 |
| Mar 5, 2025 | Baker Bros. Advisors (GP) LLC | Director, 10% Owner | Grant(A) | 64K | — | $0 |
| Dec 16, 2024 | Patel Sushil | Chief Executive Officer, Director | Sell(S) | 10K | $12.42 | $124K |
| Nov 18, 2024 | Sarchi Christopher | Chief Commercial Officer | Sell(S) | 5K | $10.78 | $56K |
| Nov 18, 2024 | Xynos Konstantinos | Chief Medical Officer | Sell(S) | 7K | $10.78 | $78K |
| Sep 4, 2024 | Balachandran Madhavan | Director | Grant(A) | 64K | — | $0 |
| Aug 30, 2024 | Astley-Sparke Philip | Executive Chairman, Director | Gift(G) | 50K | — | $0 |
| Aug 16, 2024 | Hill Emily Luisa | Chief Financial Officer | Sell(S) | 9K | $10.18 | $91K |
| Jun 7, 2024 | Xynos Konstantinos | Chief Medical Officer | Sell(S) | 16K | $7.50 | $119K |
| May 16, 2024 | Xynos Konstantinos | Chief Medical Officer | Sell(S) | 6K | $6.47 | $41K |
| May 16, 2024 | Patel Sushil | Chief Executive Officer, Director | Sell(S) | 20K | $6.47 | $131K |
| May 16, 2024 | Coffin Robert | Director | Sell(S) | 11K | $6.47 | $74K |
| May 16, 2024 | Astley-Sparke Philip | Executive Chairman, Director | Sell(S) | 38K | $6.47 | $245K |
| May 16, 2024 | Love Colin | Chief Operating Officer | Sell(S) | 18K | $6.47 | $114K |
| May 16, 2024 | Schwendenman Andrew | Chief Accounting Officer | Sell(S) | 2K | $6.47 | $15K |
| May 16, 2024 | Sarchi Christopher | Chief Commercial Officer | Sell(S) | 2K | $6.47 | $14K |
| Apr 1, 2024 | Schwendenman Andrew | Chief Accounting Officer | Grant(A) | 18K | — | $0 |
| Apr 1, 2024 | Schwendenman Andrew | Chief Accounting Officer | Grant(A) | 53K | — | $0 |
| Apr 1, 2024 | Levitsky Hyam | Director | Grant(A) | 32K | — | $0 |
| Apr 1, 2024 | Oliger Christy J. | Director | Grant(A) | 32K | — | $0 |
| Apr 1, 2024 | Sarchi Christopher | Chief Commercial Officer | Grant(A) | 22K | — | $0 |
| Apr 1, 2024 | Sarchi Christopher | Chief Commercial Officer | Grant(A) | 67K | — | $0 |
| Apr 1, 2024 | Weinand Dieter | Director | Grant(A) | 32K | — | $0 |
| Apr 1, 2024 | Slattery Joseph P | Director | Grant(A) | 32K | — | $0 |
| Apr 1, 2024 | Hill Emily Luisa | Chief Financial Officer | Grant(A) | 27K | — | $0 |
| Apr 1, 2024 | Hill Emily Luisa | Chief Financial Officer | Grant(A) | 80K | — | $0 |
| Apr 1, 2024 | Dhingra Kapil | Director | Grant(A) | 32K | — | $0 |
| Apr 1, 2024 | Xynos Konstantinos | Chief Medical Officer | Grant(A) | 27K | — | $0 |
| Apr 1, 2024 | Xynos Konstantinos | Chief Medical Officer | Grant(A) | 80K | — | $0 |
| Apr 1, 2024 | Pucci Paolo | Director | Grant(A) | 32K | — | $0 |
| Apr 1, 2024 | Patel Sushil | Chief Executive Officer, Director | Grant(A) | 83K | — | $0 |
| Apr 1, 2024 | Patel Sushil | Chief Executive Officer, Director | Grant(A) | 250K | — | $0 |
| Apr 1, 2024 | Peeples-Dyer Veleka | Director | Grant(A) | 32K | — | $0 |
| Nov 16, 2023 | Sarchi Christopher | Chief Commercial Officer | Sell(S) | 5K | $10.92 | $57K |
| Nov 16, 2023 | Xynos Konstantinos | Chief Medical Officer | Sell(S) | 7K | $10.92 | $80K |
Insider transactions sourced from SEC EDGAR Form 4 filings, normalized within minutes of acceptance. "Buy"/"Sell" mark open-market transactions (codes P/S), the tradeable signal. Awards, option exercises and tax-withholding are shown with their raw code. All data is public domain.
Coverage: Form 4 filings indexed 2021-01-04 → 2026-07-21. Earlier history is backfilling; this window widens as it deepens.
Programmatic access via the Arkolith API & MCP server (insider.transactions, insider.company).